Manuel Romero Bernardez
Has grant
Associate Professor
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Manuel Romero Bernardez is an Associate Professor at Universidade de Santiago de Compostela, Spain. His research primarily focuses on biofilm formation and quorum sensing, with recent publications discussing the role of AHL-based QS signaling in Escherichia coli and the development of biofilm models for antimicrobial testing. Additionally, his work includes the design of new quorum sensing inhibitors and the exploration of interkingdom signaling in microbial communities.
Recent Grants
Grant: Close
Transforming industry standards in healthcare: Connecting key UK interdisciplinary analytical platforms for biofilms across the National Biofilms Innovation Centre (NBIC), The National Physical Laboratory (NPL), the Singapore Centre for Environmental Life Sciences Engineering (SCELSE), and the Singapore National Biofilm Centre (SNBC)
Open Date: 2021-01-01
Close Date: 2021-03-01
Grant: Close
Molecular nanomachines for photoactivated biofilm disruption
Open Date: 2020-12-01
Close Date: 2021-11-01
Grant: Close
Biofilm disruption activity of absorbent sustained action alginate and iodine combined wound dressings
Open Date: 2020-10-01
Close Date: 2021-03-01
Grant: Close
The fungal endoplasmic reticulum stress response and its role in crop yield and soil health via biofilm formation
Open Date: 2020-09-01
Close Date: 2021-03-01
Grant: Close
Development of antibiotic adjuvant therapy for P. aeruginosa infections by targeting polysaccharide production
Open Date: 2020-03-01
Close Date: 2021-12-01
Articles (10)
Year:
2025
Year:
2025
Chronic wound infections are generally of polymicrobial nature with aerobic and anaerobic bacteria, as well as fungi frequently observed in them. Wound treatment involves a series of steps, including debridement of the wound, flushing, and often the use of multiple wound dressings many of which are antimicrobial. Yet, many wound dressings are tested versus single species of planktonic microbes, which fails to mirror the real-life presence of biofilms. Aims Simple biofilm models are the first step to testing of any antimicrobial and wound dressing; therefore, the aim of this study was to develop and validate a simple polymicrobial colony biofilm wound model comprised of Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans on RPMI-1640 agar. The model was then used to evaluate the topical disinfectant chlorohexidine and four commercially available wound dressings using the polymicrobial model. The model used was as a starting point to mimic debridement in clinical care of wounds and the effectiveness of wound dressings evaluated afterwards. Methods and Results Planktonic assessment using AATCC100-2004 demonstrated that all antimicrobial wound dressings reduced the planktonic microbial burden below the limit of detection; however, when challenged with polymicrobial colony biofilms, silver wound dressings showed limited effectiveness (1–2 log CFU reductions). In contrast, a single iodine releasing wound dressing showed potent antibiofilm activity reducing all species CFUs below the limit of detection (>6–10 log) depending on the species. A disrupted biofilm model challenge was performed to represent the debridement of a wound and wound silver-based wound dressings were found to be marginally more effective than in whole colony biofilm challenges while the iodine containing wound dressing reduced microbial recovery below the limit of detection. Conclusions In this model, silver dressings were ineffective versus the whole colony biofilms but showed some recovery of activity versus the disrupted colony biofilm. The iodine wound dressing reduced the viability of all species below the level of detection. This suggests that mode of action of wound dressing should be considered for the type of biofilm challenge as should the clinical use, e.g. debridement.
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Collaborators (15)
Saskia Camille Flament Simon
Profesor Ayudante Doctor (PDI)
Universidade de Santiago de Compostela
Fadi Soukarieh
Lecturer in Medicinal Chemistry
University of Sheffield
Alvaro Mata
Queen Mary University of London
Kim Hardie
Associate Professor
University of Nottingham
Michael Stocks
Professor
University of Nottingham
Rian L. Griffiths
University of Nottingham
Jens Andre Hammerl
Head of the Consultant Laboratory for Vibrio spp. in Food; Deputy Head of the Consilliary Laborytory for Yersinia
Federal Institute for Risk Assessment
Cameron Alexander
Professor of Polymer Therapeutics
University of Nottingham Faculty of Sciences
Javier Fernández
Associate Professor
University of Oviedo
Manuel Simões
Associate Professor with Habilitation
Universidade do Porto Faculdade de Engenharia
Miguel Cámara
University of Nottingham
Jonas Emsley
professor of macromolecular crystallography
University of Nottingham
Aurélie Carlier
Associate Professor
University of Maastricht
Pratik Gurnani
University College London
Azucena del Carmen Mora Gutiérrez
Full Professor (Catedrática de Microbiología)
-
Make your next move.
Prepare your application
Review drafts before you send them.